Expansion of VA access to the geko® device

01 Aug Expansion of VA access to the geko® device

We are proud to announce a major new distribution partnership with BIOS Strategic Partners (BIOS SP) — a recognized leader in breakthrough medical technology distribution.

Under this new collaboration, BIOS SP will introduce the geko^® device  T3 and W3 to over 40 Veterans Affairs (VA) medical facilities across the southwestern and western U.S., backed by a team of up to 20 seasoned BIOS SP sales representatives.

The geko^® device is clinically proven to:

• Prevent and treat venous thromboembolism (VTE)
• Reduce edema
• Enhance microcirculation for patients with venous insufficiency or ischemia

…it’s a non-invasive, drug-free solution that’s especially powerful for patients with limited mobility and those recovering at home.

Initial rollout will target specialties including Orthopedics, Vascular, Podiatry, and Chronic Venous Disease (CVD) care, supporting clinicians and delivering better outcomes to veterans.

“We’re proud to support our veterans with technology that truly makes a difference,” said Paul Glavovic, Partner at BIOS SP.

“Partnering with BIOS SP is a pivotal move in our mission to improve patient care across the U.S.,” added Bernard Ross, CEO of Sky Medical Technology.

With BIOS SP’s extensive VA expertise and Firstkind’s groundbreaking tech, this partnership is set to transform recovery and circulation care across the VA healthcare system.

For more about BIOS SP: BIOS LinkedIn
Read full article here.